National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
Department of Health and Human Services
Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs. Applicants may p
Funding
Award size
$100K – $1M
Award ceiling
499999
Type
Grant
Dates
Deadline
Later
Posted
11/12/2024
Closes
2027-01-07
Eligibility
Eligibility
State governmentsPublic and State controlled institutions of higher educationCity or township governmentsPrivate institutions of higher educationCounty governmentsPublic housing authorities/Indian housing authoritiesOthers (see text field entitled "Additional Information on Eligibility" for clarification)Special district governmentsIndependent school districtsNative American tribal governments (Federally recognized)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationNative American tribal organizations (other than Federally recognized tribal governments)Small businessesNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationFor profit organizations other than small businesses
Program
Funding area
Education - EDHealth - HL
Opportunity #
PAR-25-081
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov